Inspire Medical Systems (INSP)

• Market cap: $4.68B
• 1 day: -1.01%
• 5 days: -4.81%
• 1 month: -1.66%
• 3 months: -16.43%
• 6 months: -25.14%
• Year to date: -20.05%
• 1 year: -13.26%
• 5 years: 115.00%
• 10 years: 505.48%
• Sector: Healthcare
• Industry: Medical Devices

About: Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.

Employees: 1,246

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

39% more first-time investments, than exits

New positions opened: 61 | Existing positions closed: 44

33% more funds holding in top 10

Funds holding in top 10: 6 [Q3] → 8 (+2) [Q4]

4% more funds holding

Funds holding: 341 [Q3] → 353 (+12) [Q4]

0.64% more ownership

Funds ownership: 110.78% [Q3] → 111.43% (+0.64%) [Q4]

7% less repeat investments, than reductions

Existing positions increased: 116 | Existing positions reduced: 125

11% less capital invested

Capital invested by funds: $6.97B [Q3] → $6.2B (-$769M) [Q4]

26% less call options, than puts

Call options by funds: $54.8M | Put options by funds: $73.8M

Research analyst outlook

7 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $174 15% upside
• Avg. target: $202 33% upside
• High target: $236 56% upside

7 analyst ratings

• positive: 5 71%
• neutral: 2 29%
• negative: 0 0%

Morgan Stanley Kallum Titchmarsh 67% 1-year accuracy 2 / 3 met price target	32% upside $200	Overweight Maintained	6 May 2025
JP Morgan Robbie Marcus 50% 1-year accuracy 10 / 20 met price target	29% upside $195	Overweight Maintained	6 May 2025
Wells Fargo Larry Biegelsen 32% 1-year accuracy 13 / 41 met price target	15% upside $174	Equal-Weight Maintained	6 May 2025
Baird Mike Polark 58% 1-year accuracy 7 / 12 met price target	56% upside $236	Outperform Maintained	6 May 2025
Stifel Jonathan Block 25% 1-year accuracy 5 / 20 met price target	16% upside $175	Hold Maintained	21 Apr 2025